| Leases |
On
January 1, 2025, the Company assumed an office lease from Duraviva Pharma Inc. (“Duraviva”), a New York corporation under
common control, through a lease assignment agreement. The lease term extends through August 31, 2026. The Company classified the lease
as an operating lease. Upon adoption of ASC 842, the Company recognized right-of-use asset and corresponding lease liability for its
operating lease.
During
the fourth quarter of 2025, the Company entered into lease agreements for three motor vehicles with non-cancelable lease terms ranging
from 36 to 51 months.
The
following summarizes information about the Company’s leases as of June 30, 2026 and December 31, 2025.
Schedule
of Lease
| | |
2026 | | |
2025 | |
| | |
For the Three Months Ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
(Unaudited) | | |
(Unaudited) | |
| Amount recognized in the income statements | |
| | | |
| | |
| | |
| | | |
| | |
| Operating lease expense | |
$ | 40,494 | | |
$ | 17,404 | |
| | |
2026 | | |
2025 | |
| | |
For the Six Months Ended June 30, | |
| | |
2026 | | |
2025 | |
| | |
(Unaudited) | | |
(Unaudited) | |
| Amount recognized in the income statements | |
| | | |
| | |
| | |
| | | |
| | |
| Operating lease expense | |
$ | 79,938 | | |
$ | 34,807 | |
| | |
As of June 30, 2026 | | |
As of December 31, 2025 | |
| | |
(Unaudited) | | |
| |
| Amount recognized in the balance sheets | |
| | | |
| | |
| | |
| | | |
| | |
| Right-of-use assets | |
$ | 280,939 | | |
$ | 352,616 | |
| Operating lease liabilities | |
| 276,359 | | |
| 346,699 | |
| | |
| | | |
| | |
| Cash paid for amounts included in the measurement of lease liabilities | |
| | | |
| | |
| | |
| | | |
| | |
| Operating lease expense | |
$ | 80,199 | | |
$ | 93,957 | |
| | |
| | | |
| | |
| Lease commitment | |
| | | |
| | |
| | |
| | | |
| | |
| 2026 | |
$ | 99,803 | | |
$ | 136,921 | |
| 2027 | |
| 89,964 | | |
| 89,964 | |
| 2028 | |
| 77,172 | | |
| 86,766 | |
| 2029 | |
| 25,690 | | |
| 61,078 | |
| Total future minimum lease payments | |
| 292,629 | | |
| 374,729 | |
| less imputed interest | |
| (16,270 | ) | |
| (28,030 | ) |
| Present value of lease liabilities | |
$ | 276,359 | | |
$ | 346,699 | |
| | |
| | | |
| | |
| Supplemental information | |
| | | |
| | |
| | |
| | | |
| | |
| Weighted average discount rate | |
| 5.47 | % | |
| 5.47 | % |
| | |
| | | |
| | |
| Weight average remaining lease term | |
| 41 months | | |
| 47 months | |
|